Drug intelligence / Profile preview

bupivacaine + morphine (Assiut University)

Development stage
Unknown
Lead developer
Assiut University
Modality
Small Molecules
Administration
Paravertebral
01

Overview

bupivacaine + morphine is a combination analgesic regimen administered via paravertebral block (PVB) for the management of acute postoperative pain. This specific formulation, investigated by Assiut University, utilizes morphine as an adjuvant to the local anesthetic bupivacaine. Morphine acts as a potent mu-opioid receptor agonist, providing analgesia through the modulation of pain perception in the central nervous system. Bupivacaine is a long-acting local anesthetic that functions by blocking voltage-gated sodium channels, thereby inhibiting nerve impulse conduction in the paravertebral space. The combination is primarily studied for its efficacy in reducing pain scores and opioid consumption following major surgical procedures, such as breast and renal surgeries.

Other names
PVB morphineparavertebral morphinePVB morphine-Assiut University-acute postoperative pain
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)NaV (Voltage-gated sodium channels)CaV (Voltage-gated calcium channel protein complex)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on bupivacaine + morphine (Assiut University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + morphine (Assiut University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call